Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrobulbar hemodynamic changes after topical Ganfort in ocular hypertension
2008-001231-34Phase 4Active
- Sponsor
- Ramón y Cajal University Hospital
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bimatoprost + timolol in ocular hypertension (2 arms), sponsored by Ramón y Cajal University Hospital. Primary endpoint: Change in retrobulbar hemodynamics. Started Jun 2008; status: active.
02
Drugs
bimatoprost + timolol
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on 2008-001231-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001231-34.